Background and Aims: T helper 17 [Th17] cells are crucially involved in the immunopathogenesis of inflammatory bowel diseases in humans. Nevertheless, pharmacological blockade of interleukin 17A [IL17A], the Th17 signature cytokine, yielded negative results in patients with Crohn's disease [CD], and attempts to elucidate the determinants of Th17 cells' pathogenicity in the gut have so far proved unsuccessful. Here, we aimed to identify and functionally validate the pathogenic determinants of intestinal IL-17-producing T cells.
Introduction
Crohn's disease [CD] and ulcerative colitis [UC] , known as inflammatory bowel diseases [IBDs] , are chronic inflammatory disorders of the digestive tract. 1 Current theories suggest that IBD onset is secondary to an exaggerated reaction of gut-associated lymphoid tissue against the intestinal flora 2, 3 and that T helper [Th] cells, including Th17 cells, play a major role in orchestrating the inflammatory response. 4 Inflammatory bowel disease patients manifest increased amounts of intestinal Th17 cells, 5 and a genome-wide-association study identified genetic variants in the IL23R gene, encoding for the receptor of the Th-17-promoting cytokine IL-23, as independent protective factors for CD. 6 Nonetheless, a clinical trial aimed at blocking interleukin 17A in patients with luminal CD showed negative results. 7 The recent understanding that Th17 cells can be divided into at least two different subsets, on the basis of cytokine profile and pathogenicity, probably explains these apparently conflicting results. Classical Th17 cells, induced in the presence of TGFβ1 and IL-6, have been found to display regulatory activities, owing to the co-production of IL-17 and IL-10. 8 Alternative Th17 cells are instead characterized by the co-secretion of IL-17 and inflammatory cytokines, including IFNγ and GM-CSF, and can mediate pathogenic activities in experimental models of inflammation. 9 Several studies have corroborated the existence of a functional plasticity of Th17 cells towards the Th1 lineage, both in murine models and in human autoimmune diseases, including IBD. 10 The functional transition of T cells from classical Th17 to the alternative Th1/17 lineage is mostly owed to T cell activation in the presence of IL12 and IL23, produced by antigen-presenting cells in response to bacteria-derived signals, and involved in the initiation of the Th1 transcriptional program. 11 At present, the factors associated with the pathogenicity of in vivo-differentiated Th17 cells in the gut are yet to be fully elucidated. In this context, it has been suggested that IFNγ produced by in vitrodifferentiated Th17 cells might exert a pathogenic role in a murine model of intestinal inflammation. 12 On the other hand, recent evidence demonstrates that intestinal IL-17 expression acts in an IL-23-independent manner to maintain epithelial permeability through the regulation of tight junction expression. 13, 14 The inflammatory potential of Th17 cells in the gut has so far been studied either with in vitro polarized cells, 12 not fully recapitulating in vivo-occurring Th17 cells from a functional standpoint, 8, [15] [16] [17] or gut-derived Th17 cells induced in vivo by anti-CD3 antibody administration. 18 The relevant co-production of IL-10 by anti-CD3-induced intestinal Th17 cells, 19 together with their reduced IFNγ expression, can however suggest that this model is not optimal for studying Th17 pathogenic factors in vivo. Additionally, although the detrimental role of recombinant IFNγ on epithelial cell permeability has been established in in vitro models, 20 how IFNγ acts in conferring colitogenic activity to in vivodifferentiated cells in the gut is currently unknown.
In the present study, we adopted a translational approach aimed at elucidating the pathogenic factors of in vivo-generated intestinal Th17 cells in experimental intestinal inflammation and human Th17 cells isolated from the intestinal mucosa of ileal CD patients.
Material and Methods

Human subjects
Peripheral blood and intestinal specimens were obtained from 27 patients with ileal or ileocolonic Crohn's disease [CD] and 23 non-IBD controls (healthy donors [HDs] ) at the IRCCS Ospedale Maggiore Policlinico [Milan, Italy] . All the patients were categorized according to the Montreal classification. The clinical characteristics and concomitant therapies of CD patients and HDs are summarized in Table 1 Supplementary Figure 1 .
AT1, aCD3AT1 and AT2 mice were sacrificed 3 weeks after the adoptive transfer, and the immune cell infiltrate as well as the histologic score were assessed. Small intestines and colons were removed and portioned to be fixed in 10% formalin or PLP buffer for histological analysis and immunofluorescence, snap-frozen for RNA extraction, and processed for LPMCs immunophenotyping. Before portioning, colon length was measured.
Histological analysis
For histological analysis, tissue processing was performed with a LEICA PELORIS processor before paraffin embedding. Murine samples were embedded using an automated system [SAKURA Tissue-Tek]. After hematoxylin and eosin staining, snapshots of histology were taken using an Aperio CS2 microscope with a scanning resolution of 50 000 pixels per inch [0.5 µm per pixel with a ×10 zoom and 2.5 µm per pixel when scanning at ×4]. The scoring of disease activity was performed according to the criteria described in Supplementary Table 6 .
Human intestinal T cell lines and clones generation
Human Th1, Th1/17, and Th17 clones were generated via cloning by limiting dilution according to the protocol previously described For global gene expression profiling analysis, total RNA samples from healthy control and CD patients were processed according to the manufacturer's protocol, by using a GeneChip Human 
In vivo intestinal permeability measurement
The permeability of the intestinal epithelial/endothelial barrier in vivo was measured by analysis of the LPS concentration in the blood serum of mice with a LAL Chromogenic Endotoxin Quantitation Kit [Pierce, Thermo Fisher] according to the manufacturer's protocol. The supernatants collected from intestinal CD4 + T cell clones, stimulated for 3 h with PMA/ionomycin in Caco-2 medium, in the presence or absence of neutralizing Ab [anti-human -IFNγ, -IL-17A, -TNF, eBioscience 10 μg/mL, 20 μg/mL for anti-IFNγ] were applied in the lower transwell chamber. Human recombinant cytokines [rIL-1β, and rTNF, 10 μg/mL, Miltenyi] were used as positive controls.
Measurement of trans-epithelial electrical resistance
Measurements were carried out every 30 min in the first 2 h, then at 24 and 48 h after stimulation. The ohmic resistance of a blank [culture insert without cells] was measured in parallel. To obtain the sample resistance, the blank value was subtracted from the total resistance of the sample. The final unit area resistance [Ω × cm 2 ] was calculated by multiplying the sample resistance by the effective area of the membrane. For comparison among treatments with different clones, TEER was normalized to the supernatant of each unstimulated clone.
Tight junction expression on intestinal cell monolayers
Caco-2 cells were seeded on 8-well Lab-Tek culture slides [Sigma] , at a density of 10 4 cells/well in complete DMEM medium. Once 90% confluence was reached, the medium was replaced by 400 µL of supernatant derived from stimulated human T-cell clones; as negative controls, the medium alone or the supernatant of unstimulated clones were used. rIL-1b and rTNF [10 
Results
Intestinal IL-17-producing cells with different colitogenic potential were generated in vivo
Intestinal Th17 cells were generated in vivo through different experimental protocols [ Figure 1A and B], and IL-17-producing cells were tracked by the use of IL-17 eGFP/+ reporter mice. 19 The i.p. Figure 1E , F] and a lower colonic expression of Th1-associated genes, including cxcr3 [ Figure 1G ] and tnf [ Figure 1H ]. Noteworthily, the AT2 mice expressed increased colonic levels of ccl20, a chemokine promoting CCR6 + Th17 cells recruitment in the mucosa 19 [ Figure 1G ]. Colonic CD4 + T cells isolated from AT2 mice held a sustained IFNγ-secreting capacity [ Figure 1I , J and Supplementary Figure 2B] , an activated CD69 + phenotype, and expressed high levels of the guthoming integrin α4β7 [ Figure 1K ] 3 weeks post transfer. On the contrary, CD4 + T cells isolated from aCD3-AT2 mice secreted more IL-10 in both the colon and mesenteric LNs and expressed lower levels of CD69 and α4β7 [ Figure 1I -K]. To note, colonic IL-17 + cells of AT2 mice were also robustly proliferating, as indicated by the Ki-67 expression [ Figure 1L ] and the increased absolute numbers [data not shown].
Taken together, these data support the possibility of inducing in vivo intestinal Th17 cells exhibiting different pathogenic potentials associated with a skewed cytokine co-expression profile.
IFNγ conferred pathogenic activity to intestinal IL-17-producing T cells
To evaluate whether IFNγ produced by in vivo-generated intestinal IL-17 + cells contributed to their colitogenic activity, we first crossed IL-17A eGFP mice with IFNγ -/-mice [Supplementary Figure 3] . Next, IFNγ-sufficient or -deficient Th17 cells were generated in vivo by Figure 2B ] and colon length measurement [ Figure 2C ]. Colonic CD4 + T cells isolated from IFNγ -/-AT2 mice showed a reduced proliferative capacity [Supplementary Figure 4B] and a skew towards IL-10 production, suggesting a negative control of IFNγ over IL-10 production in Th17 cells [ Figure 2D ]. The latter phenomenon may also contribute to the reduction of T-cell-derived IL-17 and IL22 in IFNγ -/-AT2 mice, confirming a suppressive role of IL-10 over Th17 cytokine production. 26 The transfer of pathogenic IFNγ-sufficient Th17 cells led to a significant increase in the colonic expression of ccl20, at RNA [ Figure 2E ] and protein level [ Figure 2F ], which was not observed in recipients of IFNγ-deficient Th17 cells. No significant differences between the recipients of IFNγ-deficient or -sufficient Th17 cells were observed with regard to the colonic expression of other chemokines or inflammatory genes [ Figure 2F ], with the notable exception of tnf, which was reduced, albeit not significantly, in IFNγ -/ AT2 mice [ Figure 2G ]. In order to assess whether Th17-derived IFNγ exerted any influence over intestinal permeability, the circulating levels of lipopolysaccharide [LPS], a marker of bacterial translocation and an indirect marker of epithelial barrier integrity, 27 were measured in recipients of intestinal Th17 cells. Reduced LPS levels were found in mice receiving IFNγ-deficient as opposed to IFNγ-sufficient Th17 cells [ Figure 2H ]. This was associated with enhanced protein levels of the intestinal tight junction protein zo-1 in the intestinal epithelium [ Figure 2I ].
Taken together, these results suggest that IFNγ contributes to the pathogenic activity of in vivo-generated intestinal Th17 cells by exerting a direct effect over the epithelial barrier, and by inhibiting IL-10 intestinal expression.
Characterization of IL-17-producing cells from CD patients
We next evaluated whether the functional phenotype of murine intestinal pathogenic Th17 cells would be retained in human CD. The cytokine profile of the lamina propria CD4 + Th cells of CD patients Figure 3A -D and Supplementary Figure 5A ]. To minimize biological variability, the analysis was exclusively focused on surgical terminal ileal specimens. As previously reported, 10 a significant co-expression of IFNγ and TNF was observed in the IL-17-producing cells isolated from the CD patients, but not from the uninflamed controls [ Figure 3A and C]. In contrast, almost no IL-17 + IL10 + CD4 + cells were found in CD and HD LPMCs [ Figure 3B and D], while an increased proportion, albeit not statistically significant, of IL-17 + IL22 + was observed in CD mucosa. Next, we evaluated whether a gene expression signature for CD-derived lamina propria Th17 cells existed. Actively IL-17-secreting ileal CD4 + Th cells were ex vivo sorted from CD and HD LPMCs [ Figure 3E and Supplementary Figure 5B] Figure 3F ]. Of note, the expression of the gene encoding for IFNγ was strongly associated with CD-derived IL-17
+ T cells [ Figure 3G ], while the gene encoding for TNF was mostly associated with IL-17 -T cells. Next, a global transcriptional profiling of the sorted lamina propria IL-17-producing CD4 + T cells from CD and healthy mucosa was performed by microarray analysis on ultra-high quality RNA [ Figure 3H′′′J ]. Functional annotation clustering was performed on the 211 differentially expressed genes [149 upregulated, 62 downregulated] in CD-derived IL-17 + cells as compared with those from healthy mucosa. A significant enrichment in specific functional categories, such as responses to microbial stimuli, activation, co-stimulation, and cytokine-mediated T cell signaling was evidenced [ Figure 3I ]. Fold changes in expression levels between CD and healthy samples were depicted for genes involved in transcription regulation, proteins acting as cell surface molecules, or chemokines and cytokines [ Figure 3J ]. Interestingly, Th17 from uninflamed ileum expressed increased levels of IL-9, which is a cytokine associated with the 'classical' Th17 cell gene signature. 9, 28 Taken together, these data indicate that IL-17-secreting CD4 + T cells from CD patients express distinct cytokine and molecular profiles and confirm that IFNγ might be a distinguished attribute for human CD-derived Th17 cells. 10 
Intestinal Th1-17 clones exerted distinctive effects on epithelial cells
We next investigated whether human Th17 cells isolated from the intestinal mucosa of active CD patients conveyed similar IFNγ-mediated pathogenic effects towards the intestinal epithelium integrity. To this end, CD4 + T cells were isolated from LPMCs in six active treatment-naïve ileal CD patients. By taking advantage of a double IFNγ/IL-17-secretion assay [ Figure 4A ], lamina propria IL-17, IFNγ, or both IL-17/IFNγ actively secreting CD4 + T cells were ex vivo sorted and subsequently cloned by limiting dilution 23 in order to generate, respectively, Th17, Th1, and Th1-17 stable clones [ Figure 4B , C]. To note, the total number of clones that could be generated from each patient was variable and partly reflected the inflammatory status of the mucosa and the disease course [ Figure 4B ]. To prevent possible artifacts linked to Th17 clones plasticity, 29 the cytokine profiles of Th1, Th1-17, and Th17 CD4 + T cell clones were re-evaluated by flow cytometry before each functional assay. In addition, functional assays were performed with at least three to five independent clones for each subset.
Soluble mediators, including cytokines, produced by the immune cells during intestinal inflammation can directly act on the mucosal epithelial barrier. 30 To evaluate the contribution of Th cell-derived soluble factors to the intestinal epithelial damage, the supernatants of polyclonally activated CD-derived Th clones were applied on Caco-2 colon epithelial monolayers. Multiplexing analysis demonstrated a higher amount of IFNγ, TNF, and GM-CSF in Th1 and Th1/17-derived supernatants, which were not detected in Th17-derived supernatants [ Figure 4D ]. The supernatants of activated Th1 or Th1-17 clones, but not of Th17 clones, affected the integrity of the epithelial layer, as documented by a significant reduction in the transepithelial electrical resistance [TEER, Figure 4E ]. The pathogenic effects of Th1 and Th1-17-derived supernatants were associated with the disruption of the monolayer architecture, as shown by tight junction protein ZO-1 immunofluorescence staining [ Figure 4F ]. Annexin V staining and early apoptotic gene expression analysis in epithelial cells excluded any contribution of T cell-mediated apoptosis in modulating epithelial cell permeability [Supplementary Figure 6 ]. Importantly, ccl20 mRNA induction in Caco-2 cells was exclusively observed following stimulation by Th1/17 supernatants [ Figure 4G ]. These data confirm that IL-17-producing cells isolated from CD patients contain an elevated proportion of Th1/17 cells that exhibit pathogenic activity against the integrity of the intestinal epithelial barrier.
IFNγ produced by Th1-17 clones was responsible for pathogenicity against intestinal epithelial cells
To link the IFNγ produced by Th17 cells to the observed effects on epithelial cells permeability, supernatants of polyclonally stimulated human Th1, Th1-17, and Th17 clones were applied in vitro to Caco-2 monolayers in the presence of IFNγ neutralization [ Figure 5A ]. TEER measurement [ Figure 5A ] demonstrated that IFNγ neutralization suppressed the effect of the Th1 and Th1-17 clone supernatants, but not that of pure Th17 clones, over epithelial permeability. Additionally, IFNγ neutralization partially restored the RNA expression levels of several junctional proteins [ Figure 5B ], More importantly, it prevented architectural disruption in Caco-2 monolayers exposed to Th1-17 clones supernatants [ Figure 5C ].
In conclusion, these data confirm that IFNγ secreted by IL-17-producing T cells during intestinal inflammation has a direct pathogenic effect on the intestinal epithelium and its blockade reduces intestinal permeability by modulating tight junction expression.
Discussion
The negative outcomes of IL-17A neutralization in CD patients 7 led to a progressive reconsideration of the role of Th17 cells and Th17-derived cytokines in the modulation of intestinal inflammation and in IBD pathogenesis. The results from the present study demonstrate that in vivo-generated intestinal Th17 cells exert a pathogenic activity in the gut, which is linked to their transition towards Th1/17 cells, and is mostly mediated by IFNγ activity towards the epithelial barrier.
The plasticity of mature Th17 lymphocytes towards IFNγ production in response to inflammatory milieu is an established concept. IL-23 signalling, in particular, is a key factor mediating Th17 to Th1 transition. Similarly, the in vitro exposure of Th17 precursors to IL-23 results in the progressive extinction of IL-17A and emergence of IFNγ-producing cells.
28 Th17-Th1 transition has been also causally related to the emergence of intestinal inflammation, as the transfer of in vitro-generated Th17 cells gives rise to IFNγ-producing cells in the gut, and induces colitis that is partially reversed by IL-23 IL3  IL9  IL1A  FLT1  IL6  CXCL13  CCR7  CCR8  CXCL10  CRTAM   TRGV3  OR5B21  GPR52  GPR21  VN1R4  OR1J1  GPR34  GAV1  SELL  HLA-DRA  P2RY10  BTLA  KLRB1  CHRNA6   SSX9  ZNF836  ZNF257  ZNF730  ATF7IP2  ZNF14  ZNF438  CHURC1  E2F6  MSL3  SMARCAD1  LEF1  MED27  GTF2H1  STON1- neutralization. 28, 31 Gut-derived Th1, Th17, and Th1/17 cells exert a similar colitogenic activity, upon the switch towards Th1-like cells and IFNγ production. 32 In our study, Th17 cells, differentiated in vivo in two distinct colitis models, induced some degree of intestinal inflammation. Nevertheless, the transfer of intestinal IL-17 + cells, harvested from the adoptive transfer model, induced a higher colitis score, which was associated with a two-fold increase in T-cell IFNγ secretion. On the contrary, aCD3-derived Th17 cells showed persistent IL-10 secretion, thus confirming the previously reported ineffectiveness of IL-17 + IL-10 + cells in sustaining pathological inflammation. 8 As Th17 cells express a functional IL-10 receptor, 18 one can speculate that Th17-derived IL-10 potentially contributes to the restraining of Th17-mediated inflammation in the colon. Moreover, IL-10 neutralization was required for the efficient transition of Th17 cells towards IFNγ + production in a T cell transfer colitis model. 32 The determinants of Th17-to-Th1 transition in the gut are still to be clarified, but current evidence suggests that intestinal flora possibly plays a relevant role. 11 Morrison et al. have demonstrated that Helicobacter hepaticus infection induces intestinal Th17 cells that progressively extinguish IL-17A secretion and turn IFNγ on. 32 CD-derived LPMCs secrete IFNγ following their exposure to commensal bacteria, in a process partly mediated by IL-23 production from intestinal antigen-presenting cells. 33, 34 Finally, gut-derived Th17 cells are characterized by a T-cell antigen receptor [TCR] repertoire, which is partly skewed towards the recognition of Segmented Filamentous Bacteria [SFB] and contributes to their pathogenic functions. 35 A strong association between T cell-derived IFNγ and experimental intestinal inflammation has been long known. IFNγ neutralization inhibits colitis development in a CD45RB
hi T cell transfer model. 22 Similarly, T cells derived from IFNγ-, 36 Tbet-37 or STAT4-38 deficient mice fail to induce intestinal inflammation upon transfer. Recently, IFNγ production by in vitro-differentiated Th17 cells has been shown to contribute to their pathogenic activity. 12 However, in vitro-differentiated Th17 cells do not fully recapitulate those arising in vivo under homeostatic or inflammatory conditions. 8, 12, [15] [16] [17] Live murine cytokine-secreting cells can be easily tracked, thanks to the availability of various reporter mice. To isolate live IL-17-and IFNγ-secreting cells from human specimens, instead, we took advantage of a cytokine secretion assay coupled with cell sorting, followed either by RNA extraction or by single cell cloning. To our 
Total number of clones knowledge, this is the first time that this technique has been applied to the functional study of human intestinal T cells. This approach has proved to be technically challenging, given the reduced number of cells isolated from human intestinal specimens, their intrinsic fragility, and the complex steps required from isolation, stimulation, sorting, and cloning. Nonetheless, this technique has proved successful and allowed us to perform functional assays, and gene expression profiles, with unmanipulated CD-derived pathogenic CD4
+ human intestinal T cell subsets [Th17, Th1/17, and Th1], defined by their cytokine profile rather than by surface markers expression. [39] [40] [41] Increased epithelial barrier permeability and bacterial translocation are considered crucial events in IBD development, 3 and mucosal T cells have been shown to contribute in multiple ways. 42 Intestinal epithelial cells express IFNγR, 43 and recombinant IFNγ applied to intestinal epithelial cell lines decreases their transepithelial resistence, 44 an effect that is prevented by an anti-IFNγR antibody. 45 Here, we observed that pro-inflammatory cytokines secreted by Th1 and Th1/17 intestinal clones from IBD patients are directly responsible for the increase in epithelial barrier permeability. Th1 and Th1/17-derived IFNγ increased epithelial cell permeability by acting on the junctional proteins, particularly zonulin-1 [ZO-1]: this confirms previous data obtained with recombinant IFNγ. 46 Although IFNγ can induce apoptosis in many cell lines, alone or with IL-1b and TNF, 47 we could not observe IFNγ-induced apoptosis in epithelial cells. However, a direct association between IFNγ-dependent apoptosis and increased epithelial permeability has not been reported. 44, 45 The evidence that we have provided in this work, strongly suggests the direct contribution of IFNγ as produced by Th17 cells in sustaining an inflammatory loop in IBD patients, which originates from an increase in endothelial cell permeability and possibly facilitates bacterial translocation to the lamina propria. In murine models, repetitive enteric stress induction elevates colonic IFNγ, which increases paracellular permeability and commensal bacterial translocation, not observed in IFNγ-deficient 48 or in anti-IFNγ-treated mice. 49 To note, IFNγ also promotes the intracellular epithelial internalization of bacteria. 50, 51 Thus, our work provides the first direct association between the role of Th17-Th1 plasticity and Th17 IFNγ production in sustaining intestinal permeability and in mediating the Th17 cell's pathogenic functions during experimental intestinal inflammation and human CD. These findings potentially lead to novel therapeutic opportunities to be aimed at blocking specific Th1-associated functions in 
